Tuesday, January 11, 2022

Pfizer CEO: 2 shots 'offer very limited protection, if any'


Pfizer CEO Albert Bourla acknowledged Monday that two doses of the vaccine his company produces with BioNTech "offer very limited protection, if any" against the dominant omicron variant.

Adding a third dose, he said in an interview with Yahoo Finance, provides "reasonable protection against hospitalization and deaths."

"Against death, very good (protection), and less protection against infection," the Pfizer chief added.